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Abstract
Background: Chronic kidney disease (CKD) is a significant public health concern. In patients with CKD,
interventions that support disease self-management have shown to improve health status and quality of life. At the
moment, the use of electronic health (eHealth) technology in self-management interventions is becoming more
and more popular. Evidence suggests that eHealth-based self-management interventions can improve health-
related outcomes of patients with CKD. However, knowledge of the implementation and effectiveness of such
interventions in general, and in China in specific, is still limited. This study protocol aims to develop and tailor the
evidence-based Dutch ‘Medical Dashboard’ eHealth self-management intervention for patients suffering from CKD
in China and evaluate its implementation process and effectiveness.
Methods: To develop and tailor a Medical Dashboard intervention for the Chinese context, we will use an
Intervention Mapping (IM) approach. A literature review and mixed-method study will first be conducted to
examine the needs, beliefs, perceptions of patients with CKD and care providers towards disease (self-management)
and eHealth (self-management) interventions (IM step 1). Based on the results of step 1, we will specify outcomes,
performance objectives, and determinants, select theory-based methods and practical strategies. Knowledge
obtained from prior results and insights from stakeholders will be combined to tailor the core interventions
components of the ‘Medical Dashboard’ self-management intervention to the Chinese context (IM step 2–5). Then,
an intervention and implementation plan will be developed. Finally, a 9-month hybrid type 2 trial design will be
employed to investigate the effectiveness of the intervention using a cluster randomized controlled trial with two
parallel arms, and the implementation integrity (fidelity) and determinants of implementation (IM step 6).
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Discussion: Our study will result in the delivery of a culturally tailored, standardized eHealth self-management
intervention for patients with CKD in China, which has the potential to optimize patients’ self-management skills
and improve health status and quality of life. Moreover, it will inform future research on the tailoring and translation
of evidence-based eHealth self-management interventions in various contexts.
Trial registration: Clinicaltrials.gov NCT04212923; Registered December 30, 2019.
Keywords: eHealth, Self-management, Chronic kidney disease, China, Hybrid design, Implementation
Background
Prevalence and burden of chronic kidney disease
Chronic kidney disease (CKD) poses a significant threat
to public health [1–3]. Globally, more than 70 million
individuals are affected by CKD [4]. In China, an esti-
mated 10.8% (119.5 million) of adults suffer from CKD
[5]. CKD is defined as abnormalities of kidney structure
or function, present for more than 3 months, with severe
implications for health [6]. CKD is chronic and catego-
rized into five stages based on the level of glomerular fil-
tration rate (GFR) and albuminuria [6]. Numerous
detrimental health outcomes are linked to CKD [7].
Also, CKD increases mortality risk and hospitalization
rates, and negatively impacts the quality of life [7–9].
Additionally, health-related and societal costs of CKD
are considerable and constitute a substantial economic
burden [10–12].
Self-management and eHealth interventions for CKD
Interventions that support disease self-management (fur-
ther referred to as ‘self-management interventions’) can
have a significant impact on the health and quality of life
of patients suffering from chronic conditions in general
[13], and patients with CKD in specific [14–16]. Self-
management support is often defined as “[……] improv-
ing chronic illness outcomes consisting of patient-centered
attributes (involving patients as partners; [……]), provider
attributes (possessing adequate knowledge, skills, atti-
tudes in providing care), and organizational attributes
(putting an organized system of care in place, having
multidisciplinary team approach, using tangible and so-
cial support)” [17].
In the last decade, the use of electronic health
(eHealth) technology in self-management interventions
has become more and more popular. EHealth technol-
ogy can facilitate remote patient-provider communica-
tion and exchange of (health) data and has the potential
to increase healthcare accessibility and efficiency [18].
EHealth-based self-management interventions have been
shown to improve health-related outcomes, such as
blood pressure (BP) control and medication adherence
[19, 20], and found to be feasible and acceptable for pa-
tients with CKD and care professionals [19]. Hence, the
use of eHealth self-management interventions for
patients with CKD has become increasingly popular.
Knowledge of the implementation and effectivity of such
interventions in China and other developing countries is,
however, still lacking [21].
Medical dashboard
Researchers from the Leiden University Medical Center
(LUMC) developed ‘Medical Dashboard’, an eHealth
intervention to help support and involve patients with
CKD in their disease self-management. This platform is
used in the Outpatient Clinic Kidney Transplant of the
LUMC since February 2016. Via Medical Dashboard, pa-
tients can monitor their health from home (e.g., BP,
weight), and can exchange health data with their care
professionals. Moreover, during consultations in the out-
patient clinic, care professionals and patients can also
use Medical Dashboard to set personal health goals such
as BP control and nutrition management (e.g., energy).
In a randomized controlled trial (RCT), the use of “Med-
ical Dashboard” has been shown to improve patients’ ad-
herence to sodium restriction intake and BP control
[14]. Also, patients reported being highly satisfied with
the online disease management system used in the plat-
form [22]. All core intervention components of ‘Medical
Dashboard’ and their supporting evidence base are pre-
sented in Additional file 1.
Opportunities for eHealth interventions in China
There is significant support and momentum for the im-
plementation of eHealth based self-management inter-
ventions in China. China had 731 million internet users
(penetration rate 53%) and 1.3 billion mobile phone
users (penetration rate of 90%) in 2016, and this number
is still growing [23–26]. Furthermore, policymakers and
care experts in China have recently launched the na-
tional health strategy ‘Healthy China 2030’. This strategy
describes eHealth technology as an essential pillar to im-
prove disease self-management as well as the accessibil-
ity and cost-effectiveness of care in rural areas.
Moreover, it views eHealth technology as the preferred
medium to reach one of the main goals: ‘enable everyone
to be involved in health, share health, and be responsible
for health’ [27, 28]. Also, the prevalence rate and severe
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adverse health outcomes of CKD have put it high on the
public health agenda in China.
Study aims and research methods
In conclusion, eHealth self-management interventions
have the potential to fundamentally improve the qual-
ity of life and health outcomes of patients suffering
from CKD in China. The Medical Dashboard based
self-management intervention has been researched ex-
tensively and proven effective. Also, our research
team has a close relationship with its developers and
is therefore able to amend and upscale the interven-
tion globally. Therefore, we aim to tailor the
evidence-based Dutch intervention ‘Medical Dash-
board’ to the Chinese context and evaluate its imple-
mentation process and effectiveness. To this end, we
will use an intervention mapping (IM) approach com-
prising six steps: (1) a needs assessment, (2) prepar-
ation of change objectives matrices, (3) selection of
theory-informed intervention methods and strategies,
(4) development of a tailored ‘Medical Dashboard’
based intervention plan, (5) development of an imple-
mentation - and (6) evaluation plan.
In correspondence with the steps of IM [29], we aim
to:
➢ Phase 1: Needs, beliefs and perceptions (Step 1 of IM)
Examine the needs, beliefs, perceptions of patients
with CKD and care providers towards disease self-
management and eHealth interventions;
➢ Phase 2: Intervention and implementation
development & planning (Step 2–5 of IM)
Tailor the core components of the ‘Medical Dash-
board’ self-management intervention for patients with
CKD to the Chinese context;
➢ Phase 3: Intervention evaluation (Step 6 of IM)
Employ a hybrid type 2 trial to:
– Evaluate the effectiveness of the intervention using a
cluster RCT with two parallel arms;
– Evaluate implementation integrity (fidelity) and
determinants of implementation.
Methods
The study has been approved by the Ethics Committee
of the First Affiliated Hospital of Zhengzhou University
(reference number 2019-KY-52).
Study setting
All study phases are (to be) conducted in the First Affili-
ated Hospital of Zhengzhou University in the Henan
province in China. Henan is one of the biggest provinces
of China, and it accounts for 9% of the rural Chinese
population. An estimated 16.4% (12 million) of adults
suffer from CKD in rural areas in Henan [30]. The De-
partment of Nephrology of the First Affiliated Hospital
of Zhengzhou University has five sub-units with approxi-
mately 276 beds; more than 60,000 patients with CKD
visit the Outpatient Clinic of Department of Nephrology
each year.
Overview of study design
An overview of the study flow following the six steps of
IM is displayed in Table 1.
Phase 1
Aim
Preliminary evidence suggests that both patients’ and
care providers’ needs, beliefs (i.e., an idea or principle
judged to be true) and perceptions (i.e., the organized
cognitive representations that individuals have about a
subject) of disease (self-management) can influence their
display of health behaviors and uptake of (self-manage-
ment) interventions [31–34]. Therefore, following step 1
of IM, we will first conduct a needs assessment and
examine the needs, beliefs, perceptions of patients with
CKD and care providers towards disease (self-manage-
ment) and the use of eHealth interventions.
Design
Intervention monitoring group First, an intervention
monitoring group including both Dutch and Chinese ex-
perts and other key stakeholders will be established. This
group will consist of two researchers, one nephrologist,
one nurse in CKD practice, one implementation special-
ist, one primary care clinician, one rehabilitation therap-
ist, one patient with CKD, one patient advisor, and one
informal caregiver. The expert group has ample experi-
ence with CKD care and the implementation of
(eHealth) self-management interventions. The interven-
tion monitoring group will meet monthly throughout all
IM steps to discuss progress and the execution of major
deliverables such as the needs assessment (e.g. program
goals), intervention development (e.g. intervention con-
tent, delivery strategies), and evaluation planning (e.g.
inclusion, outcome choice, analysis).
Literature review
A scoping literature review will be conducted to identify
relevant evidence on needs toward disease management
of patients with CKD and care providers. The search
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strategy is already developed in collaboration with a cer-
tified librarian (see Additional file 2).
Mixed-method study
Research methodology
We will conduct a mixed-method study to gain insight
into the needs, beliefs, perceptions of patients with CKD,
and care providers towards disease (self-management)
and the use of eHealth (self-management) interventions.
This study will include face to face interviews, focus
group discussions, observations, and survey research.
Methods will build on an adapted version of the theoret-
ical framework on beliefs and perceptions towards
chronic lung disease used in FRESH AIR (Brakema et al.,
submitted). This adapted framework combines the
Health Belief Model [35] and the Theory of Planned Be-
havior [36] and focuses on individuals’ beliefs and per-
ceptions as well as the sociocultural context in which
the individual resides (see Fig. 1).
We will explore patients’ and care providers’: (1) be-
liefs and perceptions towards CKD and disease self-
management, (2) needs towards CKD self-management,
and (3) needs, beliefs, perceptions towards the use of
eHealth interventions in disease self-management. The
survey will consist of three validated measures: (1) ‘The
Brief Illness Perception Questionnaire’ (BIPQ) [37], (2)
‘Chronic Kidney Disease Self-management instrument’
(CKD-SM) [38], and (3) ‘Chinese eHealth Literacy Scale’
(C-eHEALS) [39]. Each questionnaire will be tested on
usability, feasibility, and acceptability by ten volunteers
patients before they are to be used on a larger scale. If
any issues arise, the questionnaires will be adapted ac-
cordingly, for instance, by reformulating specific
questions.
Sample size calculation
For the qualitative part, following principles of “purpos-
ive and convenience sampling” [40], the inclusion of par-
ticipants will be based on opportunity, willingness to
participate, and creation of diversity (e.g., different stages
of CKD, age, gender) in our sample. We will also use
snowball sampling [41], in which participants will be
asked if they know any other individuals who could par-
ticipate in the study. As there are no defined rules for
calculating sample size in qualitative studies [42], target
numbers are set for the data collection based on
Table 1 Overview of study phases
Phase IM steps Activities
I Step 1
Conduct needs assessment
• Establish an intervention monitoring group
• Perform a systematic literature review
• Conduct a mixed-methods study into needs, beliefs
& perceptions of patients with chronic kidney disease
and care providers toward chronic kidney disease
(self-management) and the use of eHealth
(self-management) interventions
II Step 2
Identify outcomes, performance objectives, and determinants
• Formulate program outcomes
• Specify performance objectives
• Specify determinants of change
• Map the performance objectives to the determinants
and create a matrix of change objectives
Step 3
Select theory-based methods and practical strategies
• Review potentially relevant theoretical methods
• Match each determinant to the relevant method(s)
• Translate methods into practical strategies to target each
determinant
• Monitoring group reaches consensus on methods and
practical strategies
Step 4
Develop a tailored ‘Medical Dashboard’ based intervention (plan)
• Develop an intervention plan by tailoring the core
components of the Dutch Medical Dashboard to the
Chinese context
• Member check with the target population
Step 5
Develop an adoption- and implementation plan
• Identify potential adopters and implementers
• Specify program use outcomes and performance
objectives
• Specify determinants of change
• Map the performance objectives to the determinants
and create a matrix of change objectives
• Design a plan for adoption and implementation
• Member check with the target population
III Step 6
Develop an intervention evaluation plan
• Specify the two-arm, hybrid 2 trial design and:
-Develop the effectiveness evaluation plan
-Develop the implementation evaluation plan
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previous literature and our experience in previous stud-
ies (Table 2). The definitive sample size for all qualitative
research elements will be determined based on when
data saturation is achieved, which is the point when no
new or relevant information is identified through the
preliminary analysis of the data [43]. For the quantitative
part, as a rule of thumb, the sample size should be 5–10
times the number of items in the questionnaires [44].
Therefore, we aim to recruit at least 230 patients in the
quantitative survey (Table 2).
Study population
The eligibility criteria of participants are detailed in
Table 3. Approximately 200 care providers, of which 60
are nephrologists, in the Department of Nephrology of
the First Affiliated Hospital of Zhengzhou University are
available for potential recruitment. The methods to be
used differ between patients and care providers following
the relevant group- and context characteristics (see de-
tails in Table 4). For instance, focus groups cannot be
held with care providers as they (1) cannot be of duty all
at the same time, and (2) work with a tight schedule,
and finding a time slot that suits all care providers is
very difficult. Moreover, we feel that patients with CKD
would be comfortable discussing their needs towards
eHealth self-management interventions in a focus group
setting, but not their needs and beliefs towards their dis-
ease in general. Hence, we will plan to discuss this topic
in face-to-face interviews. More details on the methods
use and relevant research materials used are presented
in Additional file 3.
Phase 2
Aim
Following step 2–5 of IM, we aim to tailor the core in-
terventions components of the ‘Medical Dashboard’ self-
management intervention to the Chinese context follow-
ing the results of the needs assessment performed in
Phase I.
Design
All the IM concepts used in the steps below are opera-
tionalized and further detailed in Table 5 and Fig. 2.
Step 2: preparing matrices of change objectives
First, we will formulate program outcomes [29] on all
levels as defined in the socio-ecological model [45]. This
model will help us to understand the complex interplay
Table 2 Sample size calculation in a mixed-method study
Method Sampling Participants Sample (range between records)
Face to face interview Purposive, Convenience • Care providers
• Patients
10–15 care providers minimum
10–15 patients minimum
Focus group discussion Purposive, Convenience • Patients 2–3 groups of 8–10 patients in total
Observation Purposive, Convenience • Care providers
• Patients
10–15 observations minimum
Survey Randomly • Patients 230 patients minimum
Fig. 1 Adapted version of the theoretical framework of Brakema et al (submitted). A combination of concepts of the Health Beliefs Model (green)
and the Theory of Planned Behavior (blue)
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between individual, interpersonal, community, and soci-
etal outcomes. Second, we will subdivide program out-
comes into performance objectives [29]. Third, as each
performance objective can only be reached if matching
behavioral determinants are addressed, we will break
each performance objective down into key underlying de-
terminants [29]. We will use the Theoretical Domains
Framework (TDF) to support the identification and se-
lection of relevant determinants of behavior [46]. Two
researchers will independently identify the determinants,
and discrepancies will be resolved through discussions.
Also, the intervention monitoring group will evaluate
the determinants selected based on relevance and
changeability, using the four possible consensus-based
recommendation levels proposed by Michie et al. [46].
Finally, based on the determinants identified, we will
specify change objectives [29].
Step 3: selecting theory-informed intervention methods
and practical strategies
We will first review the literature and identify relevant
theoretical methods that can potentially induce a change
in the determinants identified in step 2 [29]. Second, we
will match the selected methods with specific change ob-
jectives. Third, the selected methods will be translated
into practical strategies to target each determinant. Fi-
nally, the intervention monitoring group will rank the
practical strategies per method [46] and ensure that
these methods and practical strategies match with the
program goals.
Step 4: develop a tailored ‘medical dashboard’ based
intervention (plan)
First, we will review the results of the needs assessment,
the initial program’s logic model of change, and discuss
intervention objectives, theoretical methods, and prac-
tical strategies for each level (e.g., individual,
organization) specified in step 1–3. Second, the interven-
tion monitoring group will have a meeting to amend,
and if necessary, adapt the Medical Dashboard interven-
tion. Only surface level adaptations will be made [47],
such as the tailoring of educational content based on the
results of the needs assessment, or by extending the
intervention delivery medium to tablets or personal
computers (listed in Additional file 1). To ensure the ef-
fectiveness of the Medical Dashboard based self-
management intervention, we will not change the core
self-management intervention components of Medical
Dashboard that underline its effectivity, such as the
provision of information support or self-monitoring.
Also, the intervention monitoring group will create a
plan for developing and testing the new version of the
Medical Dashboard. Third, we will recruit five patients
and five care providers to discuss the acceptability and
Table 3 Eligibility criteria for patients with chronic kidney disease and care providers
Category Participant eligibility criteria
Inclusion criteria • Patients:
(1) aged over 18 years old;
(2) a diagnosis of chronic kidney disease (CKD) with markers of kidney damage or a glomerular filtration rate of less than
60 ml/min/1.73m2 persisting for ≥3 months based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines [6];
(3) all CKD stages (stage 1–5) following the KDIGO staging of CKD [6];
(4) Chinese speaking.
• Health care providers
(1) who work in the Department of Nephrology of the First Affiliated Hospital of Zhengzhou University
(2) are able to implement the intervention in their daily practice
Exclusion criteria • Individuals unable to provide written informed consent and use electronic application due to physical disabilities such as eyesight
problems or mental disabilities such as psychosis, personality disorders or schizophrenia (final decision for exclusion will be made
by the treating physician)
• Individuals unable to write or read.
Table 4 Field methods used for topics
Method Care providers Patients
Beliefs, perceptions,
toward chronic
kidney disease and
self-management
Needs toward
chronic kidney
disease self-
management
Needs, beliefs,
perceptions toward
eHealth self-
management
interventions
Beliefs, perceptions
toward chronic
kidney disease and
self-management
Needs toward
chronic kidney
disease self-
management
Needs, beliefs,
perceptions toward
eHealth self-
management
interventions
Face to face interview X X X X X X
Focus group
discussion
X
Observation X X X X X X
Survey X X X
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feasibility of the intervention plan (member-check). To
this end, we will use the ‘think aloud’ method [48], in
which patients and care providers can speak aloud any
words in their mind as they read through parts of the
intervention plan. The think-aloud research method has
been demonstrated to provide valid data on participant
thinking and was successfully used in other intervention
development studies [49, 50]. Based on the results ob-
tained, further modifications will be made, resulting in a
pre-tested version of the intervention plan ready for im-
plementation in practice. The description of the inter-
vention plan will follow the Template for Intervention
Description and Replication [51].
Step 5: develop an adoption and implementation plan
The goal of this step is to write a detailed adoption and
implementation plan, containing relevant strategies to
optimize intervention delivery and implementation (fi-
delity). First, we will discuss results obtained from step
1–4 and inventory local resources (e.g., connections with
primary care clinics) that may facilitate intervention im-
plementation. Second, based on all results obtained from
previous steps and our previous systematic review [21],
the intervention monitoring group will have a meeting
to pragmatically identify potential adopters and imple-
menters. Also, this group will demonstrate program use
outcomes, performance objectives and related
Table 5 The concepts from Intervention Mapping step 2–5
Concept of Intervention Mapping Definition in Bartholomew LK et al. [29]
Step 2
Program outcome Desired changes in the behavior and the environmental conditions
Performance objective The required actions to accomplish the change in the behavioral and environmental outcomes
Determinant Factors that are associated with the performance of behavior
Change objective Specific goals stating what should change at the determinants for program outcomes in different level
Step 3
Theoretical method General technique or process for influencing changes in the determinants of behaviors and environmental
conditions
Practical strategy A specific technique for the practical use of theoretical methods in ways that fit with the target group and
the context in which the intervention will be conducted
Step 4
Intervention plan A plan detailing intervention scope and sequence including delivery channels, themes, and list of the
intervention materials needed
Step 5
Implementation plan A plan detailing how intervention adoption and implementation can be supported and maintained over time.
Fig. 2 Methods and examples of the possible output of Intervention Mapping step 2–5. Step 2 (blue), step 3(red), step 4(green), step 5(purple)
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determinants of implementation. Third, the intervention
monitoring group will design the implementation plan
following Fig. 3 [52] based on Expert Recommendations
for Implementing Change list of strategies [53]. Then,
we will use the ‘think aloud’ method to obtain feedback
from patients with CKD and care providers on the im-
plementation plan. Finally, the adoption and implemen-
tation plan will be finalized with further modifications.
Phase 3
Aim
Following step 6 of IM, we will establish an intervention
evaluation plan. Our evaluation will follow a hybrid type
2 trial design, comprising of (1) a cluster RCT with two
parallel arms to study effectiveness, and (2) a process
evaluation to evaluate implementation integrity (fidelity)
and determinants of implementation.
Design
This study will consist of a 9-month, cluster RCT with
two parallel arms, integrated into a hybrid type 2 trial
[54]. The trial design and corresponding study elements
are detailed in Fig. 4. We selected an intervention dur-
ation of 9 months, as previous literature provides sup-
port that this intervention duration is sufficient to
demonstrate the impact on several self-management
outcome indicators [55, 56]. The Standard Protocol
Items: Recommendations for Interventional Trials 2013
Statement is used to report the RCT protocol [57] (see
Additional file 4), and the Standards for Reporting
Implementation Studies will be followed for reporting
the implementation study [58].
Intervention
Patients with CKD in the comparison group will receive
usual care consisting of personalized in- and outpatient
treatment based on symptoms experienced and disease
severity, as outlined in the Kidney Disease Improving
Global Outcomes (KDIGO) guidelines [6]. Patients with
CKD in the intervention group will receive the usual
care plus the culturally tailored ‘Medical Dashboard’
based self-management intervention for 9 months. Also,
care providers in the intervention arm will implement
the usual care plus the culturally tailored ‘Medical Dash-
board’ based self-management intervention for 9
months. Those who are in the comparison group will
implement the usual care. Before the start of the inter-
vention, patients with CKD and care providers will re-
ceive a face-to-face training session on the use of
Medical Dashboard. To avoid contamination, Medical
Dashboard will only be made accessible for participants
in the intervention group via a secure password-
protected registration process.
Study population, recruitment & randomization
Effectiveness; RCT Patients with CKD and care pro-
viders will be recruited from the First Affiliated Hospital
of Zhengzhou University. Recruitment strategies, inclu-
sion, and exclusion criteria are identical to those in
phase 1 (see Table 3 and Additional file 3). We
Fig. 3 Guidance for specifying implementation strategies of Proctor EK et al. [52]
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summarize the participant flow through the study in
Fig. 5. The outcomes for effectiveness are presented in
Table 6.
A cluster-randomized trial will be performed. This
means that health-care providers within different units
of the Department of Nephrology will be randomized to
either the intervention arm or the control arm using a
computer random number generator. Also, we will use
block randomization of patients. A biostatistician blind
to the study conditions will randomly allocate patients
to the intervention (group 1) or control group (group 2)
by using a computer-based block randomization proced-
ure. The number of patients in each condition with pre-
determined characteristics (i.e., CKD stage, age, gender)
will be predefined, and block sizes of 4 and 6 will be
used to ensure equal allocation to the two groups. Only
the biostatistician will know the block sizes. Thereafter,
researchers and patients will be notified of the allocation.
The care providers delivering the intervention cannot be
blind to the intervention, but will not collect data or
analyze outcomes. Those conducting statistical analyses
will be blind to group allocation until the evaluation is
completed.
Implementation study Patients with CKD, as well as
care providers in the intervention group, will participate
in the process evaluation to evaluate implementation in-
tegrity (fidelity) and determinants of implementation.
Implementation outcomes on the patient level as well as
care provider level will be evaluated, see the further
paragraph about details of outcomes of implementation.
A research assistant who will not involve in the RCT
study will collect data within process evaluation.
Sample size calculation
Effectiveness; RCT Based on previous literature [65],
we expect the mean CKD self-management score of pa-
tients in the intervention group to be approximately
102 ± 20.53 after the 9-month intervention period. When
assuming an 80% power and a two-sided significance
level of 0.05, the sample size required in each group is
38 patients [66]. Considering a dropout rate of 30% to
follow-up, the sample size of patients in this study needs
to be 98 patients in total (49 in the intervention and 49
in the comparison group).
Implementation study All patients with CKD in the
intervention group will be invited to complete the sur-
vey. Also, patients with CKD and care providers in the
intervention group will be invited and interviewed either
face to face or by telephone for the process evaluation.
We will use “purposive and convenience sampling” to
ensure diversity (e.g., CKD stage age, gender) of our
sample, especially when there are many patients who
would like to join the interview study and choices con-
cerning participation need to be made. If only a few pa-
tients indicate that they want to participate in the
interview study, we will use snowball sampling [41] to
recruit more participants. Via snowball sampling,
Fig. 4 Study schema
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current participants will be asked if they know any other
individuals who could participate in the study. As there
are no defined rules for calculating sample size in quali-
tative studies [42], we expect to conduct a minimum of
10–15 interviews minimum with patients with CKD and
care providers per group based on previous literature
and our experience in previous studies. The definitive
sample size for the interviews will be determined based
on when data saturation is achieved through the prelim-
inary analysis of the data [43].
Outcomes measures & data collection
Outcomes for the RCT evaluating the effectiveness
We plan to evaluate:
 patients’ physical outcomes including biomedical
measures,
 patients’ lifestyle and psychosocial functioning
including self-efficacy, perceptions about CKD, qual-
ity of life, anxiety and depression status,
 hospital admission, health care utilization, and cost-
benefit
A trained research assistant will conduct data collec-
tion, and the intervention monitoring group will
supervise the data collection process. We will invite par-
ticipants in both the intervention and comparison group
to visit the Department of Nephrology at the First Affili-
ated Hospital of Zhengzhou University for data collec-
tion at baseline (T0), 3 months (T1), 6 months (T2) and
9 months (T3) post-randomization. At baseline, we will
collect demographic data, including age, race, income,
education, marital status, work type of participants. To
avoid dropping out of participants, if participants cannot
come to the hospital, data will then be collected via tele-
phone interview. Table 6 provides details on the pro-
posed outcome measures and timing of the measures.
The operationalization of outcomes and descriptions of
the measurement tools used are detailed in
Additional file 5.
Outcomes for implementation integrity (fidelity), and
determinants of implementation The process evalu-
ation will be based on the RE-AIM framework [67]. The
RE-AIM model is used to comprehensively measure the
public health impact of research conducted in real-world
settings [67]. Four dimensions (with the Effectiveness do-
main being applicable above)—Reach (refers to the pro-
portion of patients with CKD and care providers reached
by our program), Adoption (refers to the proportion of
participants who use our intervention), Implementation
Fig. 5 CONSORT flow diagram for our trial
Shen et al. BMC Nephrology          (2020) 21:495 Page 10 of 16
(refer to completion as well as fidelity to the protocol),
and Maintenance will be used to evaluate the implemen-
tation only in the intervention group. We will collect the
implementation outcome measurements throughout the
9-month trial. The outcome measures for each dimen-
sion of the RE-AIM model are as described in Table 7.
We will use the Measurement Instrument for Deter-
minants of Innovations questionnaire [68, 69] to evalu-
ate the determinants of implementation. Also, individual
interviews with stakeholders (e.g. patients, care pro-
viders) will be conducted to learn more about the usabil-
ity and feasibility of Medical Dashboard, its potential for
wide-scale implementation, and barriers and facilitators
to implementation. We will categorize the determinants
identified from this mixed-method study according to
Fleuren Framework [70].
Data analysis
Qualitative data analysis
A Framework Method [71] will be used to guide our
qualitative analysis. We will structure the qualitative data
in a matrix output formed by rows (cases), columns
(codes), and ‘cells’ (summarized data). We will follow
the Consolidated Criteria for Reporting Qualitative
Health Research (COREQ) to ensure quality and validity
[72]. The preliminary analysis with proposed codes and
a data saturation grid [43] will be performed to
determine when data saturation is reached. Also, the
codes developed, and results of the preliminary analysis
will be taken into account when performing Framework
Method analysis.
Stage A: transcribing All audio-taped interviews will be
anonymized and transcribed verbatim in Chinese. Long
pauses and interruptions (relevant to the study subject)
will be noted within the text. Additionally, all partici-
pants’ names will be replaced by an ID number. Any
names mentioned during the interview will not be tran-
scribed. One researcher will perform transcription, and
another will check them to ensure content accuracy.
Stage B: familiarization Two researchers HS (female,
28 years old, a PhD student in the field of public health
and primary care) and WW (female, 23 years old, Master
of Science in Nursing) will independently read all tran-
scriptions and make contextual/reflective notes to be-
come familiar with the whole data set.
Stage C: development of an analytical framework&
coding Atlas.ti for Windows version 7.5.18 (Scientific
Software development, Berlin) will be used to analyze
our data. Our study includes four qualitative research
parts. These are research into the (1) needs, beliefs, per-
ceptions toward CKD and self-management (phase 1);
Table 6 Effectiveness outcomes and timing of measurements
Outcome Outcome
Indicators
Measures Tools Sources Timing of
measures
T0a T1b T2c T3d
Primary
Outcome
Self-management
behavior
Survey Chronic Kidney Disease Self-Management instrument [38, 56] Patient X X X X
Secondary
outcome
Biomedical status Clinical
records
Blood pressure, Bodyweight, Glomerular filtration rate, Serum albumin,
Length, Serum calcium, Serum phosphate, Serum hemoglobin, Sodium
and protein in 24 h urine, albumin/creatinine ratio, Cholesterol,
High-density lipoprotein, Low-density lipoprotein, Triglycerides,
Hemoglobin A1C, Complications
Patient X X X X
Self-efficacy Survey Chronic Kidney Disease Self-efficacy scale [56, 59] Patient X X X X
Illness perception Survey Brief Illness Perception Questionnaire [37, 60] Patient X X
Quality of life Survey The Kidney Disease Quality of Life 36-item short-form
survey [61–63]
Patient X X
Mental health Survey Hospital Anxiety and Depression Scale [64] Patient X X X
Hospital
admission
Survey The time to first acute hospital admission with an exacerbation of
CKD or death due to CKD within 9 months after randomization
Patient X
Healthcare
utilization
Survey Number of hospitalizations and emergency room visits of patients,
primary and secondary care visits
Patient X X
Cost-benefit
analysis
Records All costs delivering the interventions (e.g., materials used in the
interventions)
Program,
intervention
group
X X
Records Medical cost (e.g., cost of treatment, hospitalization rates minored
as monetary terms)
Patient X X
aAt baseline
bThree months post-randomization
cSix months post-randomization
dNine months post-randomization
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(2) needs, beliefs, perceptions toward eHealth self-
management interventions in CKD (phase 1); (3) the ac-
ceptability and usability of intervention components
(phase 3); (4) determinants of implementation of
eHealth self-management interventions (phase 3).
Therefore, based on prior literature in which specific
theoretical frameworks were used for similar research
questions [73–77], we will develop four distinct initial
coding trees. For the first and second research questions,
we will develop two coding trees based on the adapted
version of the theoretical framework of Brakema et al.,
(submitted) and the TDF [78]. The Technology Accept-
ance Model [79] will be used to develop the coding tree
for evaluating the acceptability and usability of interven-
tion components. Also, the Fleuren framework [70] will
be used to develop the coding tree for determinants of
implementation of eHealth self-management interven-
tions. The second researcher and third researcher will
check the coding tree developed and make amendments
if necessary. One researcher will then independently
code two or three transcripts using the coding tree, and
add new codes if the textual abstracts identified do not
fit with the existing set of codes. Then, this researcher
will meet with the second researcher and discuss the
newly added codes. New codes will be added into the
coding tree, and if needed, related codes will be grouped
into categories. Thus, the process will be repeated until
no new codes arise.
The final coding tree will be checked and approved by
the second researcher and the third researcher. This
coding tree will include codes and categories; all codes
and categories will be operationalized, and relevant ex-
amples will be provided.
The finalized coding tree will then be applied to each
transcript. One researcher will go through each tran-
script, highlight the meaningful textual abstracts, and as-
sign the appropriate code from the final coding tree.
Then, all codes assigned will be verified by the second
researcher. All coding differences will be discussed until
consensus is reached.
Stage D: charting data into the framework matrix
Data will be charted into matrices per research question
identified by two researchers using Microsoft Excel
2010. The matrix will comprise of one row per partici-
pant and one column per code. Interesting or illustrative
quotations will be added to the matrices.
Stage E: interpreting the data Overarching themes will
be generated from codes derived from the data set by
reviewing the matrix and making connections within
and between participants and codes. Relations, connec-
tions, and causality will be further explored and inter-
preted, and conclusions will be drawn.
As for data derived from observations, all checklists
will be digitalized and transported to Microsoft Excel
Table 7 Implementation outcomes (intervention group only)
Outcome Outcome Indicators Measures Tools Sources
Reach Number of patients (eligible,
excluded, enrolled)
Records The proportion of patients eligible to use our intervention
program, excluded, invited, and enrolled
Patient
Number of health care providers
(eligible, excluded, enrolled)
Records The proportion of care professionals eligible to use our
intervention program, excluded, invited, and enrolled
Care provider
Characteristics of participating
patients
Records Comparing participating patients to the target population
on key clinical characteristics (e.g., disease stage)
Patient
Qualitative assessment-reach Interview The barriers/facilitators to study participation Patient
Adoption Characteristics of participating
care providers
Records Comparing participating care providers to the target
population on key characteristics (e.g., work type)
Care provider
Use of program Records Frequency of materials or Medical Dashboard used Patient, care
provider
Qualitative assessment-adoption Interview The appropriateness, comfort, relative advantage, and
credibility of the intervention
Patient, care
provider
Implementation Implementation completion Interview,
observation
The implementation completion tasks will be made as a
checklist, and the completion of the task and the length
of time to finish will be checked.
Patient, care
provider
Acceptability and feasibility of
the intervention
Interview Experiences and perceptions of the intervention Patients, care
provider, research
assistant
Maintenance Follow up on the use of
Medical Dashboard
Records The use of intervention to assess long-term maintenance Records
Qualitative assessment-
maintenance
Interview Perceptions of the integration of intervention in
health facilities
Patient, care
provider
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2010. Also, all written filed notes will be digitalized and
will be taken into account to triangulate data collected
from other methods.
Quantitative data analysis
All quantitative analyses will be performed using SPSS
version 23 (IBM, Armonk, NY, USA). We will enter
the quantitative data into Microsoft Excel 2010 and
calculate descriptive statistics such as the mean,
standard deviation, median, and range of linear vari-
ables, and frequencies and percentages of categorical
variables.
To gain insight into the needs, beliefs, perceptions
of patients with CKD towards disease (self-manage-
ment) and the use of eHealth interventions in phase
1, we will use the descriptive statistics to describe pa-
tients’ demographic characteristics, BIPQ scores,
CKD-SM score, and C-eHEALS scores. Also, we will
conduct secondary analysis using (1) independent t-
tests for normally distributed continuous variables, (2)
Mann–Whitney U-tests for nonnormally distributed
variables and (3) Chi-squared or Fisher’s exact tests
for categorical variables to compare the difference be-
tween certain types of different groups of patients
with CKD (e.g., age, gender, disease stage) and BIPQ
scores, CKD SM score and C-eHEALS scores. P-
values < 0.05 and odds ratios with a 95% confidence
interval excluding one will be considered statistically
significant.
In phase 3, one of the primary hypothesis is that
patients in the intervention group, when compared to
the comparison group, will demonstrate (statistically)
significant improvement in self-management behavior
at 9 months post-randomization. Secondary hypoth-
eses are that the intervention group when compared
to patients in the comparison group, will demonstrate
(statistically) significant improvement in biomedical
status, self-efficacy, illness perception, mental health,
quality of life, hospital admission, healthcare
utilization and cost-benefit analysis at the timing of
measurement. All primary statistical analyses will be
conducted using intent-to-treat methods. The primary
goal of statistical analyses is to examine and compare
trends over time in the primary outcome. We will
replicate this analytic approach for other secondary
outcomes; secondary analyses will examine trends
over time for biomedical status, self-efficacy, illness
perception, mental health, quality of life, hospital ad-
mission, healthcare utilization, and cost-benefit ana-
lysis. We will use longitudinal, mixed-model analyses
to test the hypotheses. Exploratory analyses will assess
the impact of the intervention on primary and sec-
ondary outcomes for patients.
Mixed analysis of literature review, qualitative and
quantitative data by triangulation
We will conduct a combined analysis by merging results
of all data analysis; from the review, quantitative and
qualitative research [80]. In phase 1, the quantitative re-
sults and review results will triangulate the qualitative
results to gain insight into the perception of disease,
self-management behavior, eHealth literacy, and needs
towards CKD self-management. To this end, we will de-
velop a thematic matrix [81] that includes participants’
characteristics and data derived from surveys and emer-
ging themes from our qualitative results to summarize
patients’ illness perception, self-management behavior,
and eHealth literacy. Also, another thematic matrix will
be developed that includes study characteristics of scop-
ing review and data derived from review results and
emerging themes from our qualitative results to
summarize the needs of patients and care providers to-
wards CKD self-management. These results will be com-
bined to inform the development of ‘Medical Dashboard’
based intervention (plan) in phase 2. For instance, if the
review and qualitative results show that health education
is needed to improve CKD self-management behaviors,
we will develop the educational intervention compo-
nents in the future intervention plan. In phase 3, we will
use the results collected from the qualitative interviews
to help interpret the quantitative results from the trial.
Qualitative results will, therefore, be used to expand
upon the results of this trial to understand the imple-
mentation process as experienced by participants. For
instance, the questionnaire of determinants of imple-
mentation will be matched with the qualitative research
on determinants of implementation.
Discussion
Some research has shown that eHealth based self-
management interventions in CKD can help to improve
health-related outcomes. However, evidence on the ef-
fectiveness of CKD eHealth based self-management in-
terventions is still inconclusive [21]. Thus, our study will
gain insights into the development of theoretically based,
and target population tailored implementation of
eHealth based self-management interventions to im-
prove CKD care. Our study will add knowledge on the
implementation research of eHealth self-management
interventions in CKD care, with fitting with the needs
and priorities expressed by patients and health care pro-
fessionals. Also, this study will add evidence of the ef-
fectiveness of eHealth based self-management
interventions on CKD health outcomes.
There are some strengths to our research. First, we
will use an innovative hybrid design to concurrently
study the effectiveness and implementation of the tai-
lored ‘Medical Dashboard’ self-management intervention
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in CKD care. The hybrid designs can test the implemen-
tation process by looking inside the so-called “black
box” to see what happens in the intervention implemen-
tation and how that could affect intervention outcomes
[82, 83]. Therefore, hybrid designs can provide the po-
tential to speed the translation of intervention findings
into routine practice by optimizing the implementation
process [54]. In addition, the triangulation of both quan-
titative and qualitative results allows researchers to
understand the implementation process and intervention
effectiveness from multiple perspectives, different types
of causal pathways, and multiple types of outcome,
thereby strengthening the validity of intervention effects
[80, 82]. Second, the robust theory will be used to guide
the process of intervention development. The IM
method ensures a theory-based approach from the rec-
ognition of a need or problem to the identification of a
solution and intervention testing. To translate interven-
tions into different contexts (e.g., health care system,
population), it is essential to optimize the intervention
fit with the needs and priorities expressed by the target
population. IM was successfully applied in the develop-
ment of self-management interventions for osteoarthritis
and chronic low back pain [75], and children with CKD
[84, 85]. Also, the RE-AIM framework as utilized in this
study provides systematic guidance on how to evaluate
the intervention effect on the process and outcome level.
A major limitation of this study is that we only perform
the study within one hospital in China. Hence, findings
may not be immediately generalizable to other health
system contexts in China where the access to eHealth
technology is (more) limited. Also, the transferability
of developed Medical Dashboard self-management
intervention to routine clinical practice in primary
care may be limited and needs further exploration.
Additionally, barriers to the adoption of Medical
Dashboard may be technical issues (e.g., connectivity
issues) or a low level of eHealth literacy of partici-
pants. To address these challenges, we will include
intervention components such as the provision of on-
going technical support and eHealth literacy training
in the intervention plan.
In conclusion, our study will result in the delivery of a
culturally tailored, standardized eHealth self-
management intervention for patients with CKD in
China, which has the potential to optimize patients’ self-
management skills and improve health status and quality
of life. Also, this study can serve as proof of concept for
the use of IM and a hybrid type 2 trial design to evaluate
the implementation and effectiveness of eHealth self-
management interventions. Moreover, it will inform fu-
ture research on the tailoring and translation of
evidence-based eHealth self-management interventions
in various contexts.
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